Debut Plus

₹31.84

▼ -0.93 -2.84%

11 Sept 2026

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).

Zenlabs Ethica Limited (530697)

Volume: 963Avg Vol 1W: 3,800Avg Vol 1M: 2,26152W Range:₹16.5₹39.99
BSE www.zenlabsethica.com AI Report
Key Ratios
Checked just now
Market Cap₹21 Cr
Current Price₹31.84
Previous Close₹32.77
High / Low (52w)₹39.99 / ₹16.5
Volume963
Avg Vol (1W)3,800
Avg Vol (1M)2,261
Stock P/E874.67
Book Value₹13.07
Dividend Yield0%
ROE23.49%
ROA-6.83%
Revenue (TTM)—
Revenue Growth—
Profit Margin-5.12%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B2.44
Debt / Equity1.34
50 DMA₹29.17
200 DMA₹25.63
Day change-2.84%
SurveillanceGSM · GSM 0
Price Chart
₹31.84▼ 3.49% · 1Y
₹38₹1792K
2025-09-11
2026-09-11

20-day avg volume: 2K shares

Pros
  • Healthy return on equity of 23.5%.
  • Company is almost debt-free.
Cons
  • Revenue fell 13% YoY.
  • Stock trades at a high P/E of 875.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹13 Cr₹13 Cr₹13 Cr₹11 Cr₹12 Cr₹12 Cr₹11 Cr₹14 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-2 Cr₹0 Cr₹-1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹72 Cr₹67 Cr₹60 Cr₹57 Cr₹69 Cr₹67 Cr₹59 Cr₹51 Cr
EBITDA₹2 Cr₹2 Cr₹-1 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr
Net Profit₹1 Cr₹1 Cr₹-1 Cr₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
EPS1.881.94-1.131.181.20.750.650.41
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹30 Cr₹35 Cr₹34 Cr₹32 Cr₹38 Cr₹43 Cr₹40 Cr₹41 Cr
Total Liabilities₹23 Cr₹27 Cr₹27 Cr₹24 Cr₹29 Cr₹34 Cr₹30 Cr₹30 Cr
Equity₹7 Cr₹8 Cr₹7 Cr₹9 Cr₹9 Cr₹10 Cr₹10 Cr₹10 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-8 Cr₹0 Cr₹2 Cr₹-9 Cr₹4 Cr
Investing₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr
Financing₹-1 Cr₹0 Cr₹0 Cr₹8 Cr₹-3 Cr
Free Cash Flow₹-8 Cr₹0 Cr₹0 Cr₹-9 Cr₹4 Cr
Shareholding
Promoter 52.96% Institutions 0% Public 47.04%
Efficiency & Working Capital
ROCE5.2%
Interest Coverage1.5
Dividend Payout—
Debtor Days139 d
Inventory Days93 d
Payable Days101 d
Cash Conversion Cycle130 d
Working Capital Days232 d
Shareholding Details

As of 2026-06-30

Promoter53%
FII0%
DII0%
Institutions0%
Public47%
Promoter Pledge0%
No. of Shareholders2,717
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters59.1%59.1%53%53%53%53%53%53%53%53%53%53%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public40.9%40.9%47%47%47%47%47%47%47%47%47%47%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,1592,1992,4822,4622,6352,6302,6632,6482,7122,7742,7562,717
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Preet Remedies LimitedShareholding of Promoter and Promoter Group26.6%17,30,455
Sanjay DhirShareholding of Promoter and Promoter Group13.2%8,57,728
Sanjeev Kumar SingalShareholding of Promoter and Promoter Group13.2%8,57,574
Hitesh Popatlal OswalPublic Shareholding6.8%4,41,962
Iepf AuthorityPublic Shareholding2.5%1,61,307
B S MallikarjunaPublic Shareholding2.1%1,39,385
Bhasakarrai Kanyalal BhattPublic Shareholding1.9%1,20,945
HimjyotiShareholding of Promoter and Promoter Group0%1,000
Harjinder KaurShareholding of Promoter and Promoter Group0%1,000
Daman SinghalShareholding of Promoter and Promoter Group0%0
Kulwant KaurShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Sanjay DhirWTD & Executive Director2025
Sanjeev KumarED / MD / CEO / Promoter2025
Him JyotiNon Executive Director2025
Kuldeep SinghIndependent Non Exe. Director2025
Anurag MalhotraIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹102077
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500024143
202500024042
2025000011
Substantial Acquisitions (SAST)

5 disclosure(s)

Off Market22/03/2024 · 4,00,000
Off Market22/03/2024 · 4,00,000
-11/08/2021 · 3,59,000
Inter-se Transfer11/08/2021 · 1,79,500
Inter-se Transfer11/08/2021 · 1,79,500
Company Information
Incorporated1993
AuditorN Kumar Chhabra & Co
Investor Email[email protected] ; [email protected]
🌐 www.zenlabsethica.com ↗

📍 Plot No 194-195 3rd Flr Pha-II, Industrial Area Ram Darbar, Chandigarh, Chandigarh, 160002

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Ace Engitech LimitedYork Exports Ltd.Supreme Holdings & HospitalityPithampur Poly Products LimitedLykis LimitedPrime Property Development Corporation Ltd.Raj Rayon IndustriesGowra Leasing & Finance LimitedJagan Lamps Ltd.Asit C Mehta Financial Services Ltd.Encode Packaging India LimitedSuper Bakers (India) Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search